NCT00002035已完成不适用
Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine
Bristol-Myers Squibb36 个研究点 分布在 2 个国家目标入组 300 人开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 300
- 试验地点
- 36
研究概览
简要总结
To compare the efficacy and safety of orally administered didanosine (ddI) with orally administered zidovudine (AZT) in the treatment of patients who exhibit increasing clinical deterioration despite treatment with AZT.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (36)
Loading locations...
相似试验
已完成
2 期
Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia ComplexAIDS Dementia ComplexHIV InfectionsNCT00000657National Institute of Allergy and Infectious Diseases (NIAID)80
已完成
2 期
A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take ZidovudineHIV InfectionsNCT00000963National Institute of Allergy and Infectious Diseases (NIAID)300
已完成
不适用
A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected PatientsHIV InfectionsNCT00002207Bristol-Myers Squibb
已完成
1 期
A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIVHIV InfectionsNCT00001049National Institute of Allergy and Infectious Diseases (NIAID)180
已完成
1 期
A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related ComplexHIV InfectionsNCT00000710National Institute of Allergy and Infectious Diseases (NIAID)42